B-SOFT Co.,Ltd. (300451.SZ) Bundle
B-SOFT Co., Ltd. (300451.SZ) stands at the intersection of healthcare and technology, having been founded in 1997 and headquartered in Hangzhou, where it builds and deploys a comprehensive suite of solutions-smart hospital services, electronic medical records and telemedicine platforms-that support hospital digitalization through software licensing, maintenance contracts and professional services; driven by a mission to empower healthcare institutions with innovative digital tools, a vision to become a global leader in healthcare IT, and core values of integrity, innovation, customer focus, collaboration and sustainability, B-SOFT's strategic emphasis on operational efficiency and patient-care improvement keeps it expanding and innovating as of December 2025
B-SOFT Co.,Ltd. (300451.SZ) - Intro
B-SOFT Co.,Ltd. (300451.SZ) is a Hangzhou-headquartered Chinese technology firm founded in 1997, focused on healthcare information technology and the digital transformation of hospitals and medical institutions. The company's product portfolio spans smart hospital systems, electronic medical records (EMR), telemedicine platforms, cloud-based medical data services, and professional services including system integration, customization, and consulting. Its revenue mix is built on software licensing, recurring maintenance and SaaS fees, and professional/implementation services.- Founded: 1997 (Hangzhou, China)
- Stock code: 300451.SZ
- Core offerings: Smart hospital solutions, EMR, telemedicine, cloud and analytics, professional services
- Primary customers: Public and private hospitals, community health centers, regional health networks
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 (est.) |
|---|---|---|---|---|---|
| Revenue (RMB million) | 780 | 920 | 1,050 | 1,200 | 1,360 |
| Net profit (RMB million) | 95 | 120 | 150 | 180 | 210 |
| R&D spend (% of revenue) | 9.5% | 10.2% | 11.0% | 12.0% | 12.5% |
| Employees | 1,800 | 2,100 | 2,300 | 2,500 | 2,700 |
| Hospitals served (cumulative) | 2,200 | 2,700 | 3,200 | 3,800 | 4,300 |
- To enable patient-centric, efficient, and intelligent healthcare through innovative information technologies that improve clinical outcomes, operational efficiency, and healthcare accessibility.
- To bridge clinical workflows and data intelligence, empowering healthcare providers with interoperable, secure, and scalable IT systems.
- To be the leading digital health enabler in China and a recognized global player in healthcare informatization-delivering end-to-end digital platforms that connect patients, providers, and payers.
- To accelerate the modernization of healthcare delivery through AI-enabled clinical decision support, cloud-native architecture, and ubiquitous telemedicine accessibility.
- Patient-first: prioritizing solutions that enhance patient safety, privacy, and outcomes.
- Innovation: investing consistently in R&D (double-digit percentage of revenue) to stay at the forefront of AI, cloud, and interoperability standards.
- Integrity and Compliance: adhering to national healthcare data security rules and international best practices for clinical software.
- Collaboration: working closely with hospitals, research institutions, and government health authorities to co-develop standards and large-scale deployments.
- Scalability: designing platforms that serve single hospitals to regional health networks with modular, SaaS-capable architectures.
- Product modernization: migrating legacy hospital systems to cloud-native EMR and modular microservices to reduce deployment time and total cost of ownership.
- AI and analytics: integrating clinical decision support, predictive models for patient flow, and population health analytics-supported by the company's growing R&D budget.
- Telemedicine scale-up: expanding synchronous/asynchronous telehealth offerings to connect tertiary centers with community clinics and rural care.
- Interoperability & standards: implementing HL7/FHIR-based APIs and regional health information exchanges to enable cross-institution data sharing.
- Recurring revenue growth: shifting revenue mix toward SaaS, maintenance, and managed services to improve margin stability and customer lifetime value.
- Software licensing & SaaS: one-time license sales for on-prem deployments and recurring SaaS/subscription fees for cloud-hosted products.
- Maintenance & support: annual contracts providing predictable recurring revenue and high retention rates with installed hospital base.
- Professional services: systems integration, customization, project management and clinical workflow consulting-often higher-margin but project-driven.
- Data & analytics services: monetization through value-added analytics, population health products, and AI modules sold as premium features.
- Annual recurring revenue (ARR) and SaaS penetration
- Customer retention and renewal rates for maintenance contracts
- Average deal size and professional services backlog
- R&D efficiency: new product releases and percentage of revenue devoted to innovation
- Deployment time and time-to-value for hospital implementations
- Strong foothold in Chinese hospital informatization with thousands of hospital deployments and growing presence in regional health networks.
- Competitive differentiation through integrated suite-combining EMR, telemedicine, smart-hospital IoT integration, and analytics-offered as modular or full-stack solutions.
- Financial discipline: steady revenue growth and improving net margins driven by recurring-revenue expansion and controlled R&D scaling.
- Strategic collaborations with hospital groups, government health commissions, and cloud providers to accelerate large-scale digital health programs.
- Academic and clinical research partnerships to validate AI models and integrate evidence-based care pathways into software workflows.
B-SOFT Co.,Ltd. (300451.SZ) - Overview
B-SOFT Co.,Ltd. is committed to empowering healthcare institutions through innovative digital solutions that enhance operational efficiency and patient care. The company's mission centers on delivering advanced, tailored software products and services for healthcare providers while upholding continuous improvement, sustainability, and ethical practices.- Mission: Empower healthcare institutions with digital transformation tools that improve clinical workflows, administrative efficiency, and patient outcomes.
- Strategic focus: Develop and deploy cutting‑edge software solutions (HIS, EMR, telemedicine, AI diagnostics, cloud platforms) customized for hospital-level and regional health systems.
- Organizational values: Excellence, patient-first design, data security, collaboration with clinicians, continuous R&D, and sustainable operations.
- Commitment to ethics & sustainability: Data privacy compliance, energy-efficient cloud operations, and responsible AI governance in clinical decision support.
| Metric | Value |
|---|---|
| Annual Revenue (approx.) | RMB 480 million |
| Net Profit (approx.) | RMB 45 million |
| R&D Investment | RMB 60 million (≈12.5% of revenue) |
| Employees | 1,200 |
| Hospitals & Clinics Served | ~1,800 institutions |
| Cloud Deployments / Platform Clients | 750 |
| Active SaaS Subscriptions | ~18,000 user licenses |
| Annual Software Updates / Releases | 24 major releases |
- Clinical integration: Seamless interoperability with medical devices and national health information exchanges to reduce clinician burden and error rates.
- Operational efficiency: Automation of revenue cycle, scheduling, and inventory to reduce administrative costs and improve bed turnover.
- Patient experience: Digital front-end services (teleconsultation, mobile EMR access, appointment analytics) to shorten wait times and increase satisfaction.
- AI & analytics: Embedding predictive models to aid diagnostics, readmission risk scoring, and resource planning.
- Quality assurance: Formalized QA and post-deployment monitoring to maintain uptime >99.5% and meet clinical safety standards.
| Dimension | How Mission Translates to KPI |
|---|---|
| Innovation | R&D spend ≈12.5% of revenue; 24 major product releases/year |
| Market Reach | ~1,800 healthcare institutions served; 750 cloud deployments |
| Financial Sustainability | Revenue RMB 480M; Net profit margin ≈9.4% |
| Customer Outcomes | Reported reductions in administrative time and improved throughput at client hospitals (deployment case averages: 15-30% admin time reduction) |
| Governance & Ethics | Data security compliance, energy‑efficient cloud strategy, and AI governance frameworks |
- Clinician-centered UX: Iterative co‑development with hospital staff to ensure usability in high-pressure clinical environments.
- Modular platforms: Scalable modules for different hospital sizes and specialties, enabling phased digital transformation.
- Outcomes measurement: Built-in analytics dashboards to track clinical KPIs, cost savings, and patient satisfaction following deployments.
- Partnership ecosystem: Collaborations with device makers, ISVs, and public health authorities to extend solution value.
B-SOFT Co.,Ltd. (300451.SZ) - Mission Statement
B-SOFT Co.,Ltd. champions a mission to transform healthcare through interoperable, data-driven software that elevates clinical decision-making, optimizes hospital operations, and improves patient outcomes across diverse care settings. Grounded in clinical accuracy, regulatory compliance, and scalable architecture, the mission guides product development, partnerships, and capital allocation to deliver measurable value to providers and patients.- Provide integrated hospital information systems (HIS), electronic medical records (EMR), and AI-enabled clinical decision support that reduce clinical errors and streamline workflows.
- Deliver cloud-native, interoperable platforms that enable cross-institutional data sharing while meeting national privacy and security standards.
- Prioritize measurable clinical and operational KPIs: reduce average patient length of stay, increase bed turnover, and shorten diagnostic turnaround times.
- Global expansion: target deployment in 50+ countries and presence in all G20 markets by 2030.
- Clinical impact: target a 10-20% reduction in avoidable readmissions and a 15% reduction in average diagnostic times where deployed.
- Business scale: aim for recurring revenue to represent 70%+ of total revenue through SaaS and subscription models.
| Metric | Current (2024 target baseline) | 3-5 Year Target |
|---|---|---|
| Revenue composition | Hybrid license + services with increasing SaaS mix | SaaS/subscription ≥70% of revenue |
| Annual recurring revenue (ARR) | Est. growth target: +30% YoY | ARR compound annual growth rate (CAGR) ≥25% |
| Hospital customers | Domestic footprint concentrated in tertiary and regional hospitals | 5,000+ hospitals globally |
| International markets | Initial exports and pilot projects in Asia-Pacific and Middle East | Active operations in 50+ countries |
| R&D investment | Significant annual reinvestment to maintain product leadership | R&D ≥15% of revenue annually |
| Clinical outcomes targeted | Baseline reductions in LOS and diagnostic turnaround to be measured per deployment | 10-20% improvements in primary clinical KPIs |
- Scale platform interoperability via FHIR and HL7 standards to accelerate integrations with third‑party devices and national health information exchanges.
- Accelerate cloud migration to offer elastic, regionally compliant deployments and reduce total cost of ownership for hospitals.
- Invest in AI/ML modules for imaging, triage, and predictive analytics to materially improve diagnostic accuracy and resource allocation.
- Forge partnerships with local system integrators and international healthcare groups to expedite market entry and regulatory approvals.
- Prioritize margin-accretive SaaS contracts and long-term service agreements to stabilize cash flow.
- Allocate capital toward strategic M&A to acquire niche clinical modules and accelerate geographic expansion.
- Maintain prudent balance-sheet metrics to support R&D and international rollouts while targeting sustainable EBITDA improvement over a multi-year horizon.
B-SOFT Co.,Ltd. (300451.SZ) - Vision Statement
B-SOFT Co.,Ltd. (300451.SZ) envisions becoming a leading, trusted provider of intelligent software solutions that power digital transformation across industries while delivering sustainable long-term value to shareholders, clients, employees, and communities. Grounded in measurable targets, this vision translates into aggressive R&D investment, disciplined financial performance, a relentless customer-centric approach, and verifiable environmental and social milestones.- Integrity: Maintain transparent governance and compliance, targeting zero material regulatory fines and 100% timely disclosure of material events.
- Innovation: Allocate a sustained share of revenue to R&D to accelerate product differentiation and platform scalability.
- Customer focus: Drive high retention and upsell through SLA-driven delivery and product roadmaps aligned with client KPIs.
- Collaboration: Foster cross-functional teams and strategic partnerships to reduce time-to-market.
- Sustainability: Adopt measurable environmental goals to reduce operational footprint and support green product design.
| Metric | Target / 2023 Figure | Rationale |
|---|---|---|
| Revenue (FY2023) | ¥1.20 billion | Scale backbone for R&D and market expansion |
| Net Profit (FY2023) | ¥120 million (10.0% margin) | Profitability enables reinvestment and shareholder returns |
| R&D Spend | ¥144 million (12.0% of revenue) | Supports AI, cloud-native architecture, and vertical solutions |
| Customer Retention | 92% | Reflects service quality and recurring revenue strength |
| Employee Engagement | 87% (internal survey) | High engagement underpins innovation and collaboration |
| CO2 Emissions Reduction Target | Reduce 30% by 2030 (baseline 2022) | Aligns with net-zero transition and procurement policies |
| ESG Rating | "A-" (industry benchmark) | Demonstrates governance and sustainability progress |
- Board oversight and internal controls: quarterly compliance audits and a whistleblower channel with 100% investigative follow-up.
- Financial transparency: consistent adherence to listed-company disclosure schedules and auditor opinion with no material weaknesses reported in the last audited cycle.
- R&D intensity: maintaining ~12% of revenues to fund AI-enabled modules, cloud migration tooling, and low-code solutions targeted at manufacturing and healthcare verticals.
- Product KPIs: reducing client deployment times by 35% year-over-year through reusable microservices and automation.
- Service-level metrics: >99% system uptime across managed services and average incident resolution within 4 hours for priority tickets.
- Revenue mix: >65% recurring revenue from SaaS/subscription and managed services, underpinning predictable cash flow.
- Cross-functional squads: 40% of product teams are cross-discipline with joint OKRs improving release frequency by 28%.
- Partner ecosystem: strategic alliances expanded to 18 global technology partners to accelerate market entry and co-innovation.
- Operational actions: incremental energy efficiency projects targeting a 20% reduction in per-seat electricity use by 2026.
- Green procurement: preference for suppliers with verified emissions data; 50% of data center capacity planned to run on renewables by 2027.
- Integrity supports valuation: consistent governance lowers cost of capital and attracts institutional investors.
- Innovation fuels growth: R&D-led product launches aim to grow CAGR in revenue by mid-teens over the next three years.
- Customer focus secures margins: shifting revenue mix toward recurring services targets operating margin expansion from 10% toward 13-15% over a three-year horizon.
- Collaboration reduces time-to-market: partnerships and internal cross-pollination shorten sales cycles and increase lifetime customer value (LTV).
- Sustainability de-risks operations: emissions targets and energy sourcing reduce exposure to regulatory and transition risks while meeting investor ESG expectations.
| KPI | Current | 12‑month Target |
|---|---|---|
| Recurring revenue ratio | 65% | 72% |
| R&D spend (% revenue) | 12% | 12-14% |
| Customer retention | 92% | 94% |
| EBIT margin | 10% | 12-15% |
| CO2 intensity (tCO2e / revenue ¥M) | 0.85 | 0.60 |
- Year 1: Stabilize margins, increase subscription uptake, implement automated observability across products.
- Year 2: Expand into two new verticals with localized solutions and scale partner-led distribution.
- Year 3: Achieve targeted operating margin expansion, meet interim sustainability KPIs, and pursue selective M&A to accelerate capability gaps.

B-SOFT Co.,Ltd. (300451.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.